Bio-Connect
Figure 1. Western blotting validation for Anti-SERTAD1 Antibody A09983 Western blot (WB) analysis of SERTAD1 polyclonal antibody at 1:500 dilution Lane1:Jurkat cell lysate Lane2:sp2/0 cell lysate Lane3:PC12 cell lysate Electrophoresis was performed on a SDS-PAGE gel. To determine SDS-PAGE gel concentration
Figure 1. Western blotting validation for Anti-SERTAD1 Antibody A09983 Western blot (WB) analysis of SERTAD1 polyclonal antibody at 1:500 dilution Lane1:Jurkat cell lysate Lane2:sp2/0 cell lysate Lane3:PC12 cell lysate Electrophoresis was performed on a SDS-PAGE gel. To determine SDS-PAGE gel concentration
Figure 1. Western blotting validation for Anti-SERTAD1 Antibody A09983 Western blot (WB) analysis of SERTAD1 polyclonal antibody at 1:500 dilution Lane1:Jurkat cell lysate Lane2:sp2/0 cell lysate Lane3:PC12 cell lysate Electrophoresis was performed on a SDS-PAGE gel. To determine SDS-PAGE gel concentration

Anti-SERTAD1 Antibody

A09983
Boster Bio
ApplicationsWestern Blot
Product group Antibodies
TargetSERTAD1
100 ul
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Anti-SERTAD1 Antibody
  • Delivery Days Customer
    9
  • Applications
    Western Blot
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Gene ID29950
  • Target name
    SERTAD1
  • Target description
    SERTA domain containing 1
  • Target synonyms
    SEI1, TRIP-Br1, TRIPBR1, SERTA domain-containing protein 1, CDK4-binding protein p34SEI, CDK4-binding protein p34SEI1, SEI-1, p34(SEI-1), transcriptional regulator interacting with the PHD-bromodomain 1
  • Host
    Rabbit
  • Protein IDQ9UHV2
  • Protein Name
    SERTA domain-containing protein 1
  • Scientific Description
    Boster Bio Anti-SERTAD1 Antibody catalog # A09983. Tested in WB applications. This antibody reacts with Human,Mouse,Rat.
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Zhu SP, Mao ZF, Huang J, et al. Continuous fluoxetine administration prevents recurrence of pulmonary arterial hypertension and prolongs survival in rats. Clin Exp Pharmacol Physiol. 2009,36(8):e1-5. doi: 10.1111/j.1440-1681.2009.05181.x
    Read this paper